BourgaritA, Le ToumelinP, PagnouxC, CohenP, MahrA, Le GuemV, . Deaths occuring the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Medicine2005; 84: 323–330.
LynnJ.Caring at the end of our lives. NEJM1996; 335: 201–202.
4.
SepiilvedaC, MarlinA, YoshidaT, UllrichA.Palliative care: the World Health Organisation's global perspective. J Pain Symptom Manage2002; 24 (2):91–96.
5.
PagnouxC, GuillevinL.How can patient care be improved beyond medical treatment?Best Pract Res Clin Rheumatol2005; 19: 337–344.
6.
ParkMC, LeeSW, ParkYB, ChungNS, LeeSK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patientens using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol2005; 34: 284–292.
7.
LaneSE, WattsRA, ShepstoneL, ScottDGI. Primary systemic vasculitis: clinical features and mortality. Q J Med2005; 98: 97–111.
8.
UramotoKM, MichetCJJr, ThumbooJ, SunkuJ, O'FallonWM, GabrielSE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum1999; 42: 46–50.
9.
AirioA, KautiainenH, HakalM.Prognosis and mortality of polymyositis and dermatosmyositis patients. Clin Rheumatol2006; 25: 234–239.
10.
WolfeF, MichaudK, GefellerO, ChoiHK. Predicting mortality in patients with rheuamtoid arthritis. Arthritis Rheum2003; 48: 1530–1542.
11.
SimonS, SchittkoG, BösenbergH, Holl-UllrichK, Schwarz–EywillM.Fulminant course of a Takayasu's arteritis and rare mesenteric arterial manifestation. 2 Rheumatol2006; 65 (6):520–526.
12.
NussaumeO, BouttierS, DuchatelleJP, ValerePE, AndreassianB.Mesenteric infarction in Takayasu's arteritis. Ann Vasc Surg1990; 4: 117–121.
13.
BoersM, Dijkmans, GabrielS, Maradit-KremersH, O'DellJ, PincusT.Making an impact on mortality in rheumatoid arthritis. Arthritis Rheum2004; 50: 1734–1739.
14.
LynnJ.Perspectives on care at the close of life. Serving patients who may die soon and their families: the role of hospice and other services. JAMA2001; 285 (7):925–32.
15.
EngelJZ. Shortness of breath and chest pain with scleroderma. Tenn Med1996; 89 (10):376–377.
16.
KozoraE, EllisonMC, WestS.Depression, fatigue and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropychological battery. Arthritis Rheum2006; 55 (4):628–635.
17.
HerrickAL. Advances in palliative care for the patient with scleroderma. Curr Opin Rheumatol1996; 8 (6):555–560.
18.
GoldblattF, HillW, AhernMJ, SmithMD. Shortness of breath in systemic lupus erythematosus: a diagnostic and therapeutic dilemma. Ann Rheum Dis2002; 61 (7):588–590.
19.
PagnouxC, MahrA, CohenP, GuillevinL.Presentation and outcome of gastrointestinal involvment in systemic necrotizing vasculitides. Medicine2005; 84: 115–128.
20.
DavisonSN, SimpsonC.Hope and advance care planning in patients with end-stage renal disease: qualitative interview study. BMJ2006; 333 (7574):886.
21.
LynnJ.Learning to care for people with chronic illness facing the end of life. JAMA2000; 284: 2508–2511.
22.
LynnJ, GoldsteinNE. Advance care planning for fatal chronic illness: avoiding commonplace errors and unwarranted suffering. Ann Intern Med2003; 138: 812–818.
23.
MurraySA, BoydK, SheikhA.Palliative care in chronic illness. BMJ2005; 330: 611–612.
